Evidence map›Paper›PMID 36826568›Full record

ReviewJournal of cardiovascular development and disease2023

The Cardiac Effects of COVID-19 on Young Competitive Athletes: Results from the Outcomes Registry for Cardiac Conditions in Athletes (ORCCA).

Nathaniel Moulson, Bradley J Petek, Aaron L Baggish, Kimberly G Harmon, Stephanie A Kliethermes, Manesh R Patel, Timothy W Churchill, Jonathan A Drezner

Open access · goldAbstract readReview
In one paragraph

Review in Journal of cardiovascular development and disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Has COVID-19 led to more sudden cardiac deaths in football?Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Nathaniel MoulsonDivision of Cardiology and Sports Cardiology BC, University of British Columbia, Vancouver, BC V6T2B5, Canada.
Bradley J PetekMassachusetts General Hospital Division of Cardiology, Boston, MA 02114, USA.
Aaron L BaggishDepartment of Cardiology, Lausanne University Hospital (CHUV), CH-105 Lausanne, Switzerland.
Kimberly G HarmonDepartment of Family Medicine and Center for Sports Cardiology, University of Washington, Seattle, WA 98195, USA.
Stephanie A KliethermesDepartment of Orthopedics and Rehabilitation, University of Wisconsin Madison, Madison, WI 53705, USA.
Manesh R PatelDivision of Cardiology, Duke Heart Center, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27710, USA.
Timothy W ChurchillMassachusetts General Hospital Division of Cardiology, Boston, MA 02114, USA.
Jonathan A DreznerDepartment of Family Medicine and Center for Sports Cardiology, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0003-3519-9120
Massachusetts General Hospital · USUniversity of Washington · USDuke University · USUniversity of British Columbia · CAUniversity of Lausanne · CHUniversity of Wisconsin–Madison · US

Funding

American Heart Association Research FundsAmerican Medical Society for Sports Medicine Research Grant
6 · The paper itself

Abstract

The Outcomes Registry for Cardiac Conditions in Athletes (ORCCA) study is a large-scale prospective investigation evaluating the cardiovascular effects and outcomes of SARS-CoV-2 infection on young competitive athletes. This review provides an overview of the key results from the ORCCA study. Results from the ORCCA study have provided important insights into the clinical impact of SARS-CoV-2 infection on the cardiovascular health of young competitive athletes and informed contemporary screening and return to sport practices. Key results include defining a low prevalence of both cardiac involvement and adverse cardiovascular outcomes after SARS-CoV-2 infection and evaluating the utility of a return-to-play cardiac evaluation. Future aims of the ORCCA study include the longer-term evaluation of cardiovascular outcomes among athletes post-SARS-CoV-2 infection and the transition to investigating outcomes in young athletes with potentially high-risk genetic or structural cardiac diagnoses.

Indexed as

athletescardiovascular outcomesCOVID-19myocarditispreparticipation screeningSARS-CoV-2sudden cardiac death

Identifiers

PMID36826568
PMCPMC9964305
OpenAlexW4319438896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.